Gemcitabine radiosensitizes multiple myeloma cells to low let, but not high let, irradiation.

S. Supiot,F. Thillays,E. Rio,S. Gouard,A. Morgenstern,F. Bruchertseifer,M. Mahé,J. Chatal,F. Davodeau,M. Chérel
DOI: https://doi.org/10.1016/J.RADONC.2007.02.005
IF: 6.901
2007-04-01
Radiotherapy and Oncology
Abstract:
What problem does this paper attempt to address?